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Background: Distal Renal Tubular Acidosis is a disorder of acid-base regulation caused by functional failure of
α-intercalated cells in the distal nephron. The recessive form of the disease (which is usually associated with
sensorineural deafness) is attributable to mutations in ATP6V1B1 or ATP6V0A4, which encode the tissue-restricted
B1 and a4 subunits of the renal apical H+-ATPase. ATP6V1B1 lies adjacent to the gene encoding the homeobox
domain protein VAX2, at 2p13.3. To date, no human phenotype has been associated with VAX2 mutations.
Case presentation: The male Caucasian proband, born of a first cousin marriage, presented at 2 months with failure to
thrive, vomiting and poor urine output. No anatomical problems were identified, but investigation revealed
hyperchloremic metabolic acidosis with inappropriately alkaline urine and bilateral nephrocalcinosis. Distal Renal Tubular
Acidosis was diagnosed and audiometry confirmed hearing loss at 2 years. ATP6V0A4 was excluded from genetic
causation by intragenic SNP linkage analysis, but ATP6V1B1 completely failed to PCR-amplify in the patient, suggesting a
genomic deletion. Successful amplification of DNA flanking ATP6V1B1 facilitated systematic chromosome walking to
ascertain that the proband harbored a homozygous deletion at 2p13.3 encompassing all of ATP6V1B1 and part of VAX2;
gene dosage was halved in the parents. This results in the complete deletion of ATP6V1B1 and disruption of the VAX2
open reading frame. Later ocular examinations revealed bilateral rod / cone photoreceptor dystrophy and mild optic at-
rophy. Similar changes were not detected in an adult harbouring a disruptive mutation in ATP6V1B1.
Conclusions: The genomic deletion reported here is firstly, the only reported example of a whole gene deletion to
underlie Distal Renal Tubular Acidosis, where the clinical phenotype is indistinguishable from that of other patients
with ATP6V1B1 mutations; secondly, this is the first reported example of a human VAX2 mutation and associated ocular
phenotype, supporting speculation in the literature that VAX2 is important for correct retinal functioning.
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Most physiological functions and the ultimate survival
of all multicellular organisms depend on the mainten-
ance of constant extracellular pH (close to 7.4 in man)
and appropriate adaptations to change. The normal
human omnivorous diet creates a net acid load, which* Correspondence: fek1000@cam.ac.uk
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creativecommons.org/publicdomain/zero/1.0/requires excretion. The kidney plays a vital part in pH
regulation by extruding acid into nascent urine, with
concomitant reabsorption of bicarbonate. The two
main sites for acid-base regulation along the nephron
(the functional unit of the kidney) are the proximal
tubule, where major bicarbonate reabsorption takes
place, and the distal nephron where fine regulation is
achieved by specialized acid-handling epithelial cells,
α-intercalated cells (α-ICs). At this site, the net effect
in humans is acid secretion [1].article distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
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across their apical plasma membrane and into the urine
by specialized multi-subunit proton pumps (H+-ATPases).
H+-ATPases are also vital for acidification of intracellular
compartments such as endosomes and lysosomes. They
consist of two domains, a catalytic V1 domain responsible
for ATP hydrolysis, and a membrane-anchored V0 domain
that uses the energy thus generated to drive H+ transport.
Each domain comprises a number of separate components
such that together, the pump contains a total of at least 13
different subunits, all separately encoded [2].
On the basolateral side of α-ICs, the anion exchanger
AE1 (encoded by SLC4A1) acts as a 1:1 chloride/bicar-
bonate exchanger, where it reabsorbs bicarbonate. How
apical H+-ATPases and AE1 are functionally coupled is
not understood [1].
Failure of acid-base regulation in α-ICs results in dis-
tal Renal Tubular Acidosis (dRTA; MIM#602722 and
267300). This disease is characterized by sometimes-
severe hyperchloremic metabolic acidosis with an inappro-
priately alkaline urine (pH >5.5), usually accompanied by
hypokalemia, hypercalciuria, renal tract calcification and
in untreated cases, rickets/osteomalacia. It can occur
secondarily, particularly in autoimmune diseases such as
Sjogren’s syndrome, or can be inherited as either an auto-
somal dominant or recessive disorder. Dominant dRTA is
caused by mutations in SLC4A1 [3, 4]. We and others have
previously shown that mutations in ATP6V1B1 and
ATP6V0A4, which encode subunits B1 and a4 of the H
+-ATPase respectively, are causative of recessive dRTA
(rdRTA). These are associated with progressive sensori-
neural hearing loss (SNHL) [5–7], which is presumed due
to endolymphatic pH abnormalities [5–7]. a4 and B1 are
tissue-restricted forms of the a- and B subunits respect-
ively, who replace the ubiquitously expressed a1 and B2
forms found on intracellular membranes. Their expression
is largely restricted to the apical surface of the α-IC, male
reproductive tract and inner ear.
ATP6V1B1 maps to 2p13.3, adjacent to VAX2, which
encodes a homeobox protein transcription factor that is
almost exclusively expressed in the ventral portion of the
retina during development. To date, no human mutations
have been found in VAX2, but GWAS meta-analysis has
suggested it as a candidate to underlie astigmatism [8].
Vax2-null mice show disruptions to the establishment of a
dorsoventral axis of the neural retina, a key step in eye
development, and abnormal outgrowth of ventral retinal
ganglion cells [9, 10]. Transcriptome analysis in these mice
suggests that lack of Vax2 expression adversely affects the
distribution of retinoic acid which itself plays a major part
in correct patterning of the eye during development.
Importantly, retinoic acid is also shown to be important in
maintenance of appropriate gene expression in the photo-
receptor cells of the mature retina [11]. Some of theVax2-/- mice also display incomplete closure of the optic
fissure and coloboma (with variable penetrance) and there
is speculation in the literature that VAX2 might be respon-
sible for a similar human phenotype [9, 12].
VAX2 shares 100 % identity in the homeobox domain
with VAX1, which is strongly expressed both during early
development in the neural ridge, and later in the rostro-
medial olfactory placode, optic nerve and disc and anterior
ventral forebrain. VAX1 is known to be essential both for
corpus callosum development and correct axon guidance
in the optic nerve and forebrain [13]. A single case has
been reported wherein a mutation in VAX1 (R152S) was
found in a patient with microphthalmia, optic nerve hypo-
plasia, cleft lip/palate and corpus callosum agenesis, a
phenotype similar to that found in the Vax1 null mouse
[13, 14]. VAX2 was also screened in an additional 70
patients with anophthalmia/microphthalmia but no muta-
tions were found [14]. To date therefore, the single VAX1
case represents the only reported mutation in either hu-
man VAX gene.
Here, we describe a genomic deletion that causes both
dRTA (due to the complete absence of ATP6V1B1) and a
novel deleterious eye phenotype (due to disruption of
VAX2). This deletion represents a novel mechanism of
disease for dRTA and underpins the importance of VAX2
in maintenance of retinal integrity in man.
Case presentation
Clinical presentation
The consanguineous Caucasian kindred under study was
referred via pediatric nephrology services in Tehran, Iran.
The male patient, born to first cousin parents, presented
at 2 months of age with failure to thrive and vomiting, and
was described as having ‘difficulty in urination’. On exam-
ination there were no anatomical problems, but hyper-
chloremic metabolic acidosis with inappropriately alkaline
urine were discovered on biochemical assessment (blood
pH 7.01, HCO3 4mmol/l, urine pH > 6). Ultrasonography
revealed bilateral nephrocalcinosis. Hearing impairment
was suspected at two years old and confirmed by audiom-
etry. Visual difficulties were not reported, and both par-
ents and a sibling were clinically normal.
Genetic investigation of dRTA
Linkage analysis using previously described intragenic
SNPs within both ATP6V0A4 and ATP6V1B1 excluded
linkage to ATP6V0A4 in this family [7] (Fig. 1a). In con-
trast, none of the intragenic SNPs in ATP6V1B1 would
PCR-amplify in the patient. Multiplex PCR amplification
of both genes confirmed the integrity of the DNA tem-
plate, suggesting a genomic deletion (Fig. 1b). To investi-
gate the extent of the deletion, genes flanking ATP6V1B1
were also subjected to PCR in the proband and an unre-
lated unaffected individual. VAX2 lies immediately 5′ of
Fig. 1 Evidence that the deletion of ATP6V1B1 underlies dRTA in this family (a) ATP6V0A4 was excluded by heterozygosity of SNPs in the
patient in exons 4, 17 and 18. b Failure of PCR to amplify exons 3–4 and 13–14 of ATP6V1B1 in the patient (P) suggested a large
deletion compared to positive control (+). c Successful PCR amplification in the patient for exon 1 of VAX2 ( ) and exon 1 of ANKRD53
( ), but not exon 2 of VAX2 ( ) and exon 21 of ATP6V1B1 ( ) define regions on either side of ATP6V1B1 for the deletion breakpoints on
chromosome 2. L = 100bp ladder
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successful PCR amplification was achieved for exon 1 but
not exons 2 or 3 of VAX2, indicating that the deletion
breakpoint lay in intron 1. All exons of ANKRD53 were
successfully amplified. Further PCR was performed in the
patient and an unrelated unaffected individual to ‘walk’
systematically inwards until a segment was amplified from
control but not patient DNA. Reactions were performed
using QIAGEN’s multiplex PCR kit in a total reaction
volume of 15 μl containing 50 ng DNA. Finally, the outer-
most primers of these pairs (VAX2, intron 1 and between
ATP6V1B1 and ANKRD53) were used in combination to
amplify across the presumed deleted region in the proband
(Fig. 2a). Primer sequences are available on request. Sequen-
cing of this product was performed and analyzed by BLAT
[15]. The first 225 bp exactly matched sequence in intron 1
of VAX2. This was followed by GG, and the remainder of
the product exactly matched sequence from the region be-
tween ATP6V1B1 and ANKRD53 (Fig. 2b). This confirmed
that the deleted region was 56.8 Kb and contained 2 of the
3 coding exons of VAX2 and the known dRTA gene.
Gene dosage in family members was investigated by
semi-quantitative PCR, using primers to amplify exons
13–14 of ATP6V1B1 and exon 3 of VAX2 from genomic
DNA of the patient, both parents and an unrelated un-
affected individual. This confirmed that both parents
were heterozygous for the deletion (Fig. 2c).Investigation of a possible ocular phenotype due to loss
of VAX2
No visual problems were initially reported in this patient,
now aged 13. However, recent retrospective ophthalmo-
logical examination revealed subtle abnormalities. Cor-
rected visual acuity was 18/20 in each eye. Refraction
showed [OD +1.50 DS -0.75 DC at 120] and [OS +1.0
DS -0.75 DC at 1600]. Morphology of the external eye
was normal bilaterally, with normal ocular motility and
anterior segments. Fundal examination revealed bilateral
pigmentary changes at the macula and retinal periphery
consistent with a retinal dystrophy, and bilateral optic at-
rophy (Fig. 3). Electroretinography demonstrated reduced
amplitude a-waves in keeping with a photoreceptor dys-
trophy. Visual evoked potential amplitude was mildly
reduced, likely secondary to ganglion cell loss from the
retinal dystrophy.
To confirm that the phenotype seen in this patient
was not attributable to B1 deficiency, we arranged for
detailed retinal examination of an unrelated adult (32
year old) dRTA patient with an underlying homozygous
B1 mutation (c.687 + 1G > T; a previously reported [5]
essential splice site mutation at the exon 7/intron 7
boundary). This revealed normal retinal function with
no cellular changes (data not shown), which supports
the conclusion that VAX2 deficiency in the patient de-
scribed here is responsible for the eye phenotype.
Fig. 2 Characterization and gene dosage of the genomic deletion at 2p13.3 (a) Successful PCR amplification across the junction breakpoint in the
patient (P) and his parents (F, M) but not in a control individual with normal genomic DNA (C). b Sequencing revealed the insertion of 2
nucleotides (GG) at the site of the deletion. c Semi-quantitative PCR confirmed that gene dosage of ATP6V1B1 and exons 2 and 3 of VAX2 is
reduced in the parents (F, M) compared to the control (C)
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This is the first time that a whole gene deletion has been
found to underlie dRTA. The clinical phenotype in this pa-
tient was indistinguishable from cases caused by nonsense
or missense mutations in ATP6B1V1. However, on finding
the deletion of two of the three coding exons of VAX2, a
post-hoc ocular examination revealed an undiagnosed eye
phenotype. The patient did not manifest coloboma but
this is not particularly surprising as in Vax2-/- mice this
abnormality showed variable penetrance [9, 10]. However,
the patient described here was found to have electro-
physiological evidence of photoreceptor degeneration.Fig. 3 Fundus photographs of the right eye (left image) and left eye (right
optic atrophy can be seenAdditionally, there was optic atrophy similar to Vax2-/-
mice which may be primary or secondary to the retinal
dystrophy.
A possible mechanism for the abnormality is disrup-
tion to retinoic acid disposition in the retina, for which
VAX2 is necessary, and which is important for photo-
receptor function [11]. Both in this patient and in the
Vax2-null mouse, the phenotype is mild compared to
that associated both with a previously reported human
VAX1 mutation and a targeted murine Vax1 deletion,
where coloboma was fully penetrant and moderately
severe [13, 14]. The mild VAX2-null phenotype is likelyimage). Abnormal pigmentation around the macula and mild bilateral
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been shown to work in concert to ventralize the eye.
Vax1/Vax2 double mutant mice have a fully penetrant,
severe phenotype where the optic nerve is transformed
into differentiated retina. This is caused by loss of
repression of the Pax6 transcription factor, which pro-
motes a dorsal phenotype/retinal differentiation [16].
The normal retinal function we report in an unrelated,
adult dRTA patient with a homozygous B1 splice site
mutation excludes the possibility that the eye phenotype
seen in the case described here is attributable to a failure
of the H+-ATPase. We and others have previously dem-
onstrated expression of the tissue-restricted ATP6V0A4
and ATP6V1B1 in the eye [17–19] where it is suggested
that the proton pump contributes to intraocular fluid
homeostasis. Additionally, the role of the a3 subunit of
the H+-ATPase in correct ocular function is well docu-
mented; mutations cause severe autosomal recessive
osteopetrosis often associated with impaired vision [20]
but here, loss of sight is attributed to compression of the
optic nerve caused by failure of bone resorption by oste-
oclasts [18].
This study is important in terms of clinical and re-
search findings as it has confirmed that VAX2 plays an
important role in maintenance of the human neural
retina. In order to further understand the pathogenesis,
more patients with VAX2 mutations will need to be in-
vestigated. Although presentation of these patients has
not to date been forthcoming, they may now be easier
to identify as we have some a priori knowledge of how
the phenotype might present.
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